Aflibercept in Age-Related Macular Degeneration: Evaluating Its Role as a Primary Therapeutic Option

Eye - United Kingdom
doi 10.1038/eye.2017.81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016English

Correction:Current Therapeutic Developments in Atrophic Age-Related Macular Degeneration

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2016English

PPAR-αLigands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration

PPAR Research
Drug DiscoveryPharmacology
2008English

Age-Related Macular Degeneration

2013English

Age Related Macular Degeneration

BMJ
2010English

Aflibercept Improves Outcome in Eyes With Poor Vision From Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2016English

Age-Related Macular Degeneration

2012English

Age-Related Macular Degeneration

2014English

Age-Related Macular Degeneration

Medical radiology
Nuclear MedicineRadiologyImaging
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy